LEQVIO 284 MG/1.5ML PREFILLED SYRINGE

LEQVIO IS INDICATED IN ADULTS WITH PRIMARY HYPERCHOLESTEROLAEMIA (HETEROZYGOUS FAMILIAL AND NON-FAMILIAL) OR MIXED DYSLIPIDAEMIA AS AN ADJUNCT TO DIET: � IN COMBINATION WITH A STATIN OR STATIN WITH OTHER LIPID-LOWERING THERAPIES IN PATIENTS UNABLE TO REACH LDL-C GOALS WITH THE MAXIMUM TOLERATED DOSE OF A STATIN OR � ALONE OR IN COMBINATION WITH OTHER LIPID-LOWERING THERAPIES IN PATIENTS WHO ARE STATIN-INTOLERANT OR FOR WHOM A STATIN IS CONTRAINDICATED. THE RECOMMENDED DOSE IS 284 MG INCLISIRAN ADMINISTERED AS A SINGLE SUBCUTANEOUS INJECTION: INITIALLY AGAIN AT 3 MONTHS FOLLOWED BY EVERY 6 MONTHS.